Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iopanoic Acid SCHEMBL29358912 | 1.00 | LMNA (1.00) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| SCHEMBL18609115 | 0.88 | LMNA (0.79) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| SCHEMBL8336112 | 0.88 | LMNA (0.78) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| SCHEMBL18922031 | 0.88 | LMNA (0.78) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| Iopanoic Acid SCHEMBL31609799 | 0.85 | LMNA (0.74) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| Iophenoxic Acid SCHEMBL966564 | 0.83 | TDP1 (1.00) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| SCHEMBL10495750 | 0.82 | CYP1A2 (0.70) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| SCHEMBL9002219 | 0.80 | LMNA (0.66) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| SCHEMBL9002211 | 0.80 | LMNA (0.66) | LMNACYP2C9CYP1A2CHRM1TBXA2R | |
| SCHEMBL10001207 | 0.79 | LMNA (0.66) | LMNACYP2C9CYP1A2CHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3596 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12582717-B2 | Protein based excipient for active pharmaceutical ingredients | DISPERSOME IP APS (NL) | 2026-03-24 | — | — | US | claimed |
| US-20260000646-A1 | Inhibition of Oral Microbe Biofilms | THE UNIVERSITY OF TOLEDO (US) | 2026-01-01 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250170279-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2025-05-29 | — | — | US | claimed |
| US-20250170280-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2025-05-29 | — | — | US | claimed |
| US-20240293441-A1 | NEW THERAPEUTIC USE OF TYPE 2 IODOTHYRONINE DEIODINASE (D2) INHIBITORS | CHEIRONTECH S.R.L. (IT) | 2024-09-05 | — | — | US | claimed |
| US-20240226000-A9 | TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS | DYVE BIOSCIENCES, INC. | 2024-07-11 | — | — | US | claimed |
| US-20240139003-A1 | BIORESORBABLE STENT AND METHOD FOR MANUFACTURING THE SAME | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2024-05-02 | — | — | US | claimed |
| US-20240130962-A1 | TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS | DYVE BIOSCIENCES INC (US) | 2024-04-25 | — | — | US | claimed |
| EP-4346841-A1 | NEW THERAPEUTIC USE OF TYPE 2 IODOTHYRONINE DEIODINASE (D2) INHIBITORS | Dompé Farmaceutici S.p.A. (IT) | 2024-04-10 | — | — | EP | claimed |
| EP-0649302-A1 | THERAPEUTIC AND DIAGNOSTIC USE OF MODIFIED POLYMERIC MICROCAPSULES | WALLACE, Sidney (US) | 1995-04-26 | — | — | EP | claimed |
| WO-1995008116-A1 | METHOD OF DETECTING CYTOPENIA THAT IS MEDIATED BY DRUG-DEPENDENT ANTIBODY BINDING TO BLOOD CELLS | THE BLOOD CENTER OF SOUTHEASTERN WISCONSIN, INC. (US) | 1995-03-23 | — | — | WO | claimed |
| WO-1994027644-A1 | IODINATED PARAMAGNETIC CHELATES, AND THEIR USE AS CONTRAST AGENTS | BRACCO S.P.A. (IT) | 1994-12-08 | — | — | WO | claimed |
| EP-0414806-B1 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX | LIPOSOME CO INC (US) | 1994-07-20 | — | — | EP | claimed |
| WO-1994005335-A1 | NEW ORGANIC CONTRAST AGENT ANALOG AND METHOD OF MAKING SAME | MOLECULAR BIOSYSTEMS, INC. (US) | 1994-03-17 | — | — | WO | claimed |
| WO-1994002106-A1 | THERAPEUTIC AND DIAGNOSTIC USE OF MODIFIED POLYMERIC MICROCAPSULES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-02-03 | — | — | WO | claimed |
| EP-0414806-A4 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX | — | 1991-11-13 | — | — | EP | claimed |
| EP-0414806-A1 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX. | LIPOSOME CO INC (US) | 1991-03-06 | — | — | EP | claimed |
| WO-1989011272-A1 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX | THE LIPOSOME COMPANY, INC. (US) | 1989-11-30 | — | — | WO | claimed |
| US-4192859-A | MEDICAL DIAGNOSIS USING X-RAYS | E. R. SQUIBB & SONS, INC. (US) | 1980-03-11 | — | — | US | claimed |